-
Discrete Event Simulation and Treatment Sequencing Cost-Effectiveness Model in Second-Line Highly Active Relapse Remitting Multiple Sclerosis for a NICE Multiple Technology Appraisal
Sep 9, 2025, 16:22 PM -
Internal Validation of Type 2 Diabetes and Cardiovascular Events Incidences in the Core Obesity and Diabetes Model
Sep 9, 2025, 16:22 PM -
Simulated Treatment Comparisons in NICE Technology Appraisals: Frequency Trends and Implications
Sep 9, 2025, 16:22 PM -
Does Insurance Value in Metastatic Breast Cancer Vary by Age Testing for Variation in Willingness to Pay for Novel Treatments Among Women in the US?
Sep 9, 2025, 16:22 PM -
Inequality in Vaccine Uptake: Lessons Learned From Denmark Analyzing Real-World Data From National Registries
Sep 9, 2025, 16:22 PM -
Cardiovascular Effects of Semaglutide in Patients With Obesity, With or Without Type 2 Diabetes (T2DM): An Umbrella Review
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of the 13-Valent Pneumococcal Conjugate Vaccine Compared With Higher-Valent Alternatives in the Pediatric Population of Paraguay
Sep 9, 2025, 16:22 PM -
The Relationship Between Surrogate Endpoints and Overall Survival in Myelofibrosis Clinical Trials: Results From a Targeted Literature Review
Sep 9, 2025, 16:22 PM -
How Can the Threshold Method Guide the Choice of Treatments? Illustration in French Patients With Hemophilia A or B
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Control-IQ Hybrid Closed-Loop System in Adults With Type 1 Diabetes in Sweden
Sep 9, 2025, 16:22 PM -
Study Design Trends in Registry-Based Oncology Studies: Analysis of HMA-EMA Real-World Data Catalogs
Sep 9, 2025, 16:22 PM -
Development of a Preliminary Conceptual Model to Capture the Adult Patient Experience of Follicular Lymphoma
Sep 9, 2025, 16:22 PM -
NICE Guidance, Not-So-NICE Realities: Resource Constraints in HTA
Sep 9, 2025, 16:22 PM -
Biomarker Levels in Patients With Ulcerative Colitis Post-Advanced Therapy Induction: A Real-World Survey in Europe
Sep 9, 2025, 16:22 PM -
Bayesian Network Meta-Analysis of Weight Loss Efficacy for GLP-1 Receptor Agonists and Tirzepatide
Sep 9, 2025, 16:22 PM -
Premature Cancer-Related Morbidity and Mortality in Israel: Years Lived With Disability and Years of Life Lost Productivity Costs
Sep 9, 2025, 16:22 PM -
Development and Evaluation of a Proactive Monitoring Model for Adverse Drug Events in Patients With Pulmonary Arterial Hypertension Based on the Delphi and Real-World Data
Sep 9, 2025, 16:22 PM -
Systematic Review of Prognostic Factors and Treatment Effect Modifiers for Transthyretin Amyloid Cardiomyopathy
Sep 9, 2025, 16:22 PM -
Burden of Duchenne Muscular Dystrophy in Italy: A Multicenter Cost of Illness Study
Sep 9, 2025, 16:22 PM -
Transporting Treatment Effects for Survival Outcomes Under Informative Censoring: A Simulation Study Using Summary-Level Data in the Target Population
Sep 9, 2025, 16:22 PM